Back to results
US 2021/0227769 A1Published application
New Guinea Impatiens Variety SAKIMP061
AssigneeSakata Seed Corporation
InventorChihiro Sato
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeSakata Seed Corporation
InventorChihiro Sato
Estimating the term…
A New Guinea Impatiens plant designated SAKIMP061 is disclosed. Embodiments include seeds of New Guinea Impatiens SAKIMP061, plants of New Guinea Impatiens SAKIMP061, to plant parts of New Guinea Impatiens SAKIMP061, and methods for producing an impatiens plant produced by crossing New Guinea Impatiens SAKIMP061 with itself or with another impatiens variety. Embodiments include methods for producing an impatiens plant containing in its genetic material one or more genes or transgenes and transgenic impatiens plants and plant parts produced by those methods. Embodiments also relate to impatiens varieties, breeding varieties, plant parts, and cells derived from New Guinea Impatiens SAKIMP061, methods for producing other impatiens lines or plant parts derived from New Guinea Impatiens SAKIMP061, and the impatiens plants, varieties, and their parts derived from use of those methods. Embodiments further include hybrid impatiens seeds, plants, and plant parts produced by crossing New Guinea Impatiens SAKIMP061 with another impatiens variety.
A plant of New Guinea Impatiens variety SAKIMP061, wherein a representative sample of plant tissue of SAKIMP061 was deposited under NCMA No. ______.
A method for developing a New Guinea Impatiens plant in a plant breeding program, comprising applying plant breeding techniques comprising crossing, recurrent selection, mutation breeding, wherein said mutation breeding selects for a mutation that is spontaneously or naturally induced or artificially induced, backcrossing, pedigree breeding, marker enhanced selection, haploid/double haploid production, or transformation to a plant of New Guinea Impatiens variety SAKIMP061, wherein a representative sample of plant tissue of SAKIMP061 was deposited under NCMA No. ______, or its parts, wherein application of said techniques results in development of a New Guinea Impatiens plant.
A method of editing the genome of New Guinea Impatiens plant SAKIMP061, wherein a representative sample of plant tissue of SAKIMP061 was deposited under NCMA No. ______, wherein said method is selected from the group comprising zinc finger nucleases, transcription activator-like effector nucleases (TALENs), engineered homing endonucleases/meganucleases, and the clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein9 (Cas9) system.
Dependencies are inferred from the claim text.